Article
Re‐adapting T cells for cancer therapy: from mouse models to clinical trials
13 Dec 2013
Abstract excerpt
Adoptive T-cell therapy involves the isolation, expansion, and reinfusion of T lymphocytes with a defined specificity and function as a means to eradicate cancer. Our research has focused on specifying the requirements for tumor eradication with antigen-specific T cells and T cells transduced to express a defined T-cell receptor (TCR) in mouse models and then translating these strategies to clinical trials. Our...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
